{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:03:26Z","timestamp":1790877806668,"version":"4.1.0"},"reference-count":34,"publisher":"BMJ","funder":[{"name":"Jiangsu Frontier Technology Research and Development Program","award":["BF2025635"],"award-info":[{"award-number":["BF2025635"]}]},{"name":"Gusu Leading Talent Plan for Scientific and Technological Innovation and Entrepreneurship","award":["ZXL2023345"],"award-info":[{"award-number":["ZXL2023345"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2026,9,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart-type fatty acid-binding protein (H-FABP), a principal intracellular transporter of long-chain fatty acids (FAs), has been investigated as an early diagnostic biomarker for acute myocardial infarction (MI) and acute coronary syndrome. However, evidence regarding its associations with long-term risk of cardiac events and potential interaction with omega-3 FAs remains scarce. Therefore, we aimed to investigate these associations in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 42\u2009392 participants from the UK Biobank who were free of coronary heart disease (CHD) and heart failure (HF) at baseline. Plasma levels of H-FABP were quantified using the Olink platform. Multivariable Cox regression was used to evaluate the associations of H-FABP with incident CHD and HF, considering potential interaction with omega-3 FAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Elevated H-FABP levels were consistently associated with a higher risk of CHD (HR\n                      <jats:sub>T3 vs T1<\/jats:sub>\n                      =1.29), MI (HR\n                      <jats:sub>T3 vs T1<\/jats:sub>\n                      =1.54), CHD-related mortality (HR\n                      <jats:sub>T3 vs T1<\/jats:sub>\n                      =2.04) and HF (HR\n                      <jats:sub>T3 vs T1<\/jats:sub>\n                      =1.95) (all P-trend values &lt;0.001). These associations appeared to be modified by plasma levels of omega-3 FAs, especially so for CHD (P-interaction=0.014) and MI (P-interaction=0.003). Comparing the extreme tertiles of H-FABP, HRs (95%\u2009CI) of CHD and MI were 1.41 (1.15 to 1.74)\u2009and 2.23 (1.57 to 3.15), respectively, among participants with lower omega-3 FAs, and 1.15 (0.96 to 1.38)\u2009and 1.11 (0.83 to 1.50), respectively, among those with higher omega-3 FAs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher plasma levels of H-FABP were associated with a higher risk of CHD and HF in the general population, predominantly among individuals with low levels of omega-3 FAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2026-327893","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:26:12Z","timestamp":1790875572000},"page":"heartjnl-2026-327893","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma heart-type fatty acid-binding protein, omega-3 fatty acids and adverse cardiac events in the general population"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7230-7995","authenticated-orcid":false,"given":"Jie-Qiong","family":"Lyu","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"},{"name":"MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4804-5285","authenticated-orcid":false,"given":"Yu-Wen","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yuan","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qiang","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, The Second People's Hospital of Lianyungang, Lianyungang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital, School of Public Health, Suzhou Medical College, Soochow University, Suzhou, China"},{"name":"MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100110202531000_heartjnl-2026-327893v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2026100110202531000_heartjnl-2026-327893v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)87731-X"},{"key":"2026100110202531000_heartjnl-2026-327893v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2008.06.009"},{"key":"2026100110202531000_heartjnl-2026-327893v1.4","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2000.034"},{"key":"2026100110202531000_heartjnl-2026-327893v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hch037"},{"key":"2026100110202531000_heartjnl-2026-327893v1.6","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.056143"},{"key":"2026100110202531000_heartjnl-2026-327893v1.7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/07853890.2020.1800075","article-title":"Heart-type fatty acid-binding protein: an overlooked cardiac biomarker","volume":"52","author":"Goel","year":"2020","journal-title":"Ann Med"},{"key":"2026100110202531000_heartjnl-2026-327893v1.8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.34172\/jcvtr.33039","article-title":"Association of H-FABP with cardiovascular events: A systematic review","volume":"16","author":"Parekumbel Venu","year":"2024","journal-title":"J Cardiovasc Thorac Res"},{"key":"2026100110202531000_heartjnl-2026-327893v1.9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.mayocp.2020.08.034","article-title":"Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials","volume":"96","author":"Bernasconi","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026100110202531000_heartjnl-2026-327893v1.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044440"},{"key":"2026100110202531000_heartjnl-2026-327893v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812792"},{"key":"2026100110202531000_heartjnl-2026-327893v1.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2026100110202531000_heartjnl-2026-327893v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586023-06592-6"},{"key":"2026100110202531000_heartjnl-2026-327893v1.14","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010204","article-title":"An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health","volume":"13","author":"Elagizi","year":"2021","journal-title":"Nutrients"},{"key":"2026100110202531000_heartjnl-2026-327893v1.15","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-2493","article-title":"Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026100110202531000_heartjnl-2026-327893v1.16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2022.01.424","article-title":"Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study","volume":"80","author":"Schneider","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026100110202531000_heartjnl-2026-327893v1.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"2026100110202531000_heartjnl-2026-327893v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.026"},{"key":"2026100110202531000_heartjnl-2026-327893v1.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000075"},{"key":"2026100110202531000_heartjnl-2026-327893v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.37"},{"key":"2026100110202531000_heartjnl-2026-327893v1.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1768"},{"key":"2026100110202531000_heartjnl-2026-327893v1.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1708"},{"key":"2026100110202531000_heartjnl-2026-327893v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.048"},{"key":"2026100110202531000_heartjnl-2026-327893v1.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32210-x","article-title":"The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease","volume":"8","author":"Ho","year":"2018","journal-title":"Sci Rep"},{"key":"2026100110202531000_heartjnl-2026-327893v1.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS One"},{"key":"2026100110202531000_heartjnl-2026-327893v1.26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/bph.17451","article-title":"Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis","volume":"182","author":"Wu","year":"2025","journal-title":"British J Pharmacology"},{"key":"2026100110202531000_heartjnl-2026-327893v1.27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/biomedicines10092283","article-title":"The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases","volume":"10","author":"Li","year":"2022","journal-title":"Biomedicines"},{"key":"2026100110202531000_heartjnl-2026-327893v1.28","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-37"},{"key":"2026100110202531000_heartjnl-2026-327893v1.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M314263200"},{"key":"2026100110202531000_heartjnl-2026-327893v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.07.003"},{"key":"2026100110202531000_heartjnl-2026-327893v1.31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0960327116646621","article-title":"Asymmetric dimethylarginine and heart-type fatty acid-binding protein 3 are risk markers of cardiotoxicity in carbon monoxide poisoning cases in Zagazig university hospitals","volume":"36","author":"Abass","year":"2017","journal-title":"Hum Exp Toxicol"},{"key":"2026100110202531000_heartjnl-2026-327893v1.32","doi-asserted-by":"crossref","first-page":"100997","DOI":"10.1016\/j.eclinm.2021.100997","article-title":"Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis","volume":"38","author":"Khan","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2026100110202531000_heartjnl-2026-327893v1.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-015-0049-7","article-title":"A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals","volume":"14","author":"Leslie","year":"2015","journal-title":"Lipids Health Dis"},{"key":"2026100110202531000_heartjnl-2026-327893v1.34","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s10787-025-01744-8","article-title":"Dose-dependent effects of omega-3 polyunsaturated fatty acids on C-reactive protein concentrations in cardiometabolic disorders: a dose-response meta-analysis of randomized clinical trials","volume":"33","author":"Amlashi","year":"2025","journal-title":"Inflammopharmacology"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2026-327893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:26:15Z","timestamp":1790875575000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2026-327893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":34,"alternative-id":["10.1136\/heartjnl-2026-327893"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2026-327893","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}